X/XVI Congress of Neurologists of Serbia with International Participation

PROGRAMME
Day 1 – Friday, 23 October 2015
Large Hall Hall 4 Hall 5-6 Hall 1-2
Registration 8:00-9:00
9:00-10:30 9:00-10:30 9:00-10:30
Cerebrovascular Epilepsies 1 Neurodegenerative
diseases 1 diseases 1
Lessons from 100+
Stroke - PRO ET surgeries of Cerebellar ataxias
CONTRA pharmacoresistant
epilepsies
Coffee break 10:30-10:45
10:45-11:45
Plenary lecture

Laszlo Csiba
Neurosonology: past,
present…and?
Pause 11:45-12:00 h
12:00-13:00 12:00-13:00 12:00-12:30 12:00-
14:00
Satelite symposium Satellite symposium Satellite symposium
Boehringer Richter Gedeon Eli Lilly
Ingelheim
M. Žarkov Z. Stević
Lj. Beslać- Etiology and Cymbalta - Reaching the Poster
Bumbaširević pathogenesis of treatment goal in painful session
G.Mitić cerebral small vessel diabetic neuropathy
Clinical aspects of disease
application of new oral 12:40h- 13:00
anticoagulants in M. Mijajlović Satellite symposium
secondary prevention Treatment of vascular Worwag
of stroke cognitive impairment

D. Lavrnić
Myorelaxants – Frasineanu Armand
treatment that cannot Daniel
be avoided
Detection of undisclosed
neuropathy and
assessment on its impact
on quality of life: a survey
in 25000 Romanian
diabetic patients
Lunch 13:00-14:00

Novi Sad, 22nd to 24th October 2015.

1
 X/XVI Congress of Neurologists of Serbia with International Participation

Day 1 – Friday, 23 October 2015 cont’d

Large hall Hall 4 Hall 5-6 Hall 1-2
14:00-15:00 14:00-15:00 14:00-15:00
Satellite symposium Satellite symposium Satellite symposium
Merck Pfizer GlaxoSmithKlin

Treatment of multiple D. Lavrnić V. S. Kostić

sclerosis: first-line Neuropathic component Dopaminergic system
drugs in Serbia of chronic lumbar and Parkinson’s
Č. NaĎ painful syndrome disease
Modified scheme of MS
treatment: first-line
treatment M. Svetel
I. Dujmović Significance of
Bašuroski continuous
Biomarkers in the dopaminergic
prediction of treatment stimulation
response to first-line
tratment E. Stefanova
J. Drulović Dopamine agonists-
Treatment of people new possibilities
with MS: 10 years of
experience in Serbia
Č. NaĎ
Treatment of people
with MS in Serbia:
yesterday, today,
tomorrow
Pause 15:00-15:15
15:15-16:15 15:15-16:15 15:15-16:15
Satelite symposium Young neurologists 1 Satelite symposium
Medtronic Novartis

G. Milašinović D. Sokić
Contemporary How an organism takes
diagnosis of syncopes carbamazepine from a
of unknown origin tablet: CR vs.
D. Kovačević cconventional
Silent AF and medication
cryptogenic stroke M. Semnic
B. Ferek-Petrić Tretment of
Modern pacemaker Alzheimer’s disease:
technology in shifting limits
neurology
Coffee break 16:15 -17:00h
17:00-18:30 17:00-18:30 17:00-18:30
Cerebrovascular Epilepsies 2 Neurodegenerative
diseases 2 diseases 2
Age-dependent
Endovascular treatment epileptic syndromes Tratment of Parkinson’s
of acute ischemic disease
stroke

Novi Sad, 22nd to 24th October 2015.

2
 X/XVI Congress of Neurologists of Serbia with International Participation

Day 2 – Saturday, 24 October 2015

Large hall Hall 4 Hall 5-6 Hall 1-2
08:30-10:00 08:30-10:00 08:30-10:00
Cerebrovascular Epilepsies 3 Neurodegenerative
diseases 3 diseases 3
Lessons in
Ischemic stroke - pharmacological Atypical parkinsonisms
dilemmas treatment of
epilepsy
Coffee break 10:00-10:15h
10:15-10:45 10:15-10:45 10:15-10:45
Satellite symposium Satellite Satellite symposium
Bayer symposium Pharma Swiss
El Pharma
Lj. Beslać E. Stefanova
Bumbaširević M. Svetel Dual mechanisms of
New oral anticoagulants Tratment of action in the treatment
– eficaous protection is Parkinson’s disease of Alzheimer’s dementia
important! New oral – from antivirotics
anticoagulants before to antiparkinsonics
and after i.v.
thrombolysis in the
treatment of acute
ishemic stroke
Pause 10:45-11:00 h
11:00-12:00 11:00-12:00 11:00-12:00
Satellite symposium Headache – mini Satellite symposium
Pfizer symposium: Goodwill

H. Christoph Diener Headache due to M. Svetel

Secondary prevention disorders of the Long-term effficacy of
of stroke in atrial CSF pressure dopamine agonists in
fibrilation: Are we in the initial treatment of
the era of direct oral Parkinson’s disease
anticoagulanats?
D. Sokić
Treatment of epilepsy
impedes treatment of
other diseases -
inductors vs.
antiepileptics

Pause 12:00-12:15h

Novi Sad, 22nd to 24th October 2015.

3
 X/XVI Congress of Neurologists of Serbia with International Participation

Day 2 – Saturday, 24 October 2015 cont’d

Large room Room 4 Room 5-6 Room 1-2

12:15-12:45 12:15-12:45 12:15-12:45 12:00-
14:00
Satellite symposium Satellite Satellite symposium
Mylan symposium Actavis
Berlin-Chemie
A. Ješić D. Sokić , A. Ristić Poster
Challenges in the D. Lavrnić Which arrow hits the session
treatment of vertigo Painful diabetic target when surgery of
neuropathy – epilepsy is not possible?
challenges in the
diagnosis and
treatment

Lunch break 13:00-14:00 h

14:00-14:30 14:00-14:30 14:00-14:30
Satellite symposium Satellite Satellite symposium
Medtronic symposium Lundbeck
Medis
D. Chudy E. Stefanova
DBS (Deep brain J. Drulović Alzheimer’s disease,
stimulation): State of Treatment of hopes and challenges –
the art and future multiple sclerosis: is everything told?
perspective What is new?

Coffee break 14:30 -14:45

14:45-16:15 14:45-16:15 14:45-16:15
Neuromuscular Young News in
diseases – Mini neurologists 2 neurogenetics – Mini
symposium symposium

16:15-17:00 DNS Assembly and awarding “Prof. Dr. Zvonimir Levic” prize for the
best poster
17:00-18:30 17:00-18:30 17:00-18:30
Cerebrovascular Epilepsies 4 Neurodegenerative
diseases 4 diseases 4
Symptomatic
Intravenous epilepsies Non-Alzheimer dementia
thrombolytic treatment
- Do we have answers
to all the questions?

Novi Sad, 22nd to 24th October 2015.

4